维普期刊资源整合服务平台（V6.5）

247篇 您的检索式：作者名="PIRKER R"

选中清除导出查看参考文献查看引证文献引用追踪共13页首页上一页第1页下一页末页 /13 跳转

	题名	作者	年代	出处	被引量
1	Characterization of immunotoxins active against ovarian cancer cell lines显示文摘	PIRKER R FITZGERALD DJP HAMILTON TC	1985	J Clin Invest1985，76，3：	1
2	Paclitaxel/cisplatin in advanced non-small-cell lung cancer (NSCLC)显示文摘	Pirker R Krajnik G Zochbauer S et a1		0，，08：	1
3	High D-dimer levels are associated withpoor prognosis in cancer patient显示文摘	Ay C Dunkler D Pirker R		Haematologica0，97，8：	1
4	Safety and efficacy of darbepo- etin alpha in previously untreated extensive-stage smallceu lung cancer treated with platinum plus etoposide 显示文摘	Pirker R Ramlau RA Schuette W	2008	J Clin 0ncol2008，36，14：	1
5	EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer : analysis of data from the phase 3 FLEX study显示文摘	Pirker R Pereira J R von Pawel J	2012	Lancet Oncol2012，13，1：	1
6	Cetuximab plus chemotherapy in patients with advanced non - small - cell lung cancer (FLEX) : an open - label randomised phase III trial 显示文摘	Pirker R Pereira JR Szczesna A	2009	Lancet2009，373，5：	1
7	Cetuximab plus chemo-therapy in patients with advanced non-small-cell lung cancer(FLEX) : an open-label randomised phase HI trial显示文摘	Pirker R Pereira JR Szczesna A	2009	Lancet2009，373，9674：	1
8	Chemotherapy of advanced non-small cell lung cancer显示文摘	Pirker R Minar W	2010	Front Radiat Ther Oncol2010，42，：	1
9	Hemoglobin decline in cancer patients receiving chemotherapy without an agent 显示文摘	Pirker R Pirolli M Quigley J	2013	Support Care Cancer2013，21，4：	1
10	Cetuximah plus chemo- therapy in patients with advanced non-small-cell lung cancer (FLEX) : an open-label randomised phase III trial 显示文摘	Pirker R Pereira JR Szczesna A	2009	Lancet2009，373，9674：	1
11	Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase m trial 显示文摘	Pirker R Pereira JR Szczesna A	2009	Lancet2009，373，9674：	1
12	High Ibdimer levels are associated with poor prognosis in cancer patients 显示文摘	Ay C Dunkler D Pirker R	2012	Haematologica2012，97，8：	1
13	Cetuximab plus chemo- therapy in patients with advanced non - small - cell lung cancer (flex) : an open - label randomized phase Ⅲ trial 显示文摘	Pirker R Pereria JR Szczesna A	2009	Lancet2009，373，9674：	1
14	Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop显示文摘	Pirker R Herth FJ Kerr KM	2010	J Thorac Oncol2010，5，10：	1
15	Paclitaxel/cisplatin in advanced non-small cell lung cancer (NSCLC)显示文摘	Krajnik G Zochbauer S	1995	Ann Oncol1995，6，8：	1
16	Safety and efficacy of darbepoetin alpha in previously untreated extensive-stage small-cell lung cancer treated with platinum plus etoposide显示文摘	Pirker R Ramlau RA Schuette W	2008	J Clin Oncol2008，36，14：	1
17	FLEX:A randomized,multicenter,phaseⅢstudy of cetuximab in combination with cis-platin/vinorelbine(CV)versus CV alone in the fistline treatmentof patients with advanced non-small cell lung cancer(NSCLC)显示文摘	Pirker R Szczesna A von Pawel J	2008	J Clin Oncol2008，26，18：	1
18	EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study显示文摘	Pirker R Pereira JR von Pawel J	2012	Lancet Oncol2012，13，1：	1
19	The lung resistance Protein (LRP) Predicts poor outcome in acute myeloid leukemia显示文摘	Pohl G Stranzl T	1999	Adv Exp Med Biol1999，457，：	1
20	Paclitaxel/cisplatin in advanced non-small cell lung cancer显示文摘	Pirker R Krajnik G Zochbauer S	1995	Ann Oncol1995，6，：	1

返回顶部每页显示：

共13页首页上一页第1页下一页末页 /13 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示